 | |
 Testosterone propionate (top) andtestosterone ketolaurate (bottom) | |
| Combination of | |
|---|---|
| Testosterone propionate | Androgen; Anabolic steroid |
| Testosterone ketolaurate | Androgen; Anabolic steroid |
| Clinical data | |
| Trade names | Testosid-Depot |
| Other names | TP/TKL |
| Routes of administration | Intramuscular injection |
Testosterone propionate/testosterone ketolaurate (TP/TKL), sold under the brand name Testosid-Depot, is an injectable combination medication of testosterone propionate (TP), an androgen/anabolic steroid, and testosterone ketolaurate (TKL; testosterone caprinoylacetate), an androgen/anabolic steroid. It contains 25 mg TP and 150 to 300 mg TKL in oil solution and is administered by intramuscular injection at regular intervals. The medication has been reported to have a duration of action of about 14 to 20 days.
| Medication | Form | Major brand names | Duration |
|---|---|---|---|
| Testosterone | Aqueous suspension | Andronaq, Sterotate, Virosterone | 2–3 days |
| Testosterone propionate | Oil solution | Androteston, Perandren, Testoviron | 3–4 days |
| Testosterone phenylpropionate | Oil solution | Testolent | 8 days |
| Testosterone isobutyrate | Aqueous suspension | Agovirin Depot, Perandren M | 14 days |
| Mixed testosterone esters | Oil solution | Triolandren | 10–20 days |
| Mixed testosterone esters | Oil solution | Testosid Depot | 14–20 days |
| Testosterone enanthate | Oil solution | Delatestryl | 14–28 days |
| Testosterone cypionate | Oil solution | Depovirin | 14–28 days |
| Mixed testosterone esters | Oil solution | Sustanon 250 | 28 days |
| Testosterone undecanoate | Oil solution | Aveed, Nebido | 100 days |
| Testosterone buciclate | Aqueous suspension | 20 Aet-1, CDB-1781 | 90–120 days |
| Nandrolone phenylpropionate | Oil solution | Durabolin | 10 days |
| Nandrolone decanoate | Oil solution | Deca Durabolin | 21–28 days |
| Methandriol | Aqueous suspension | Notandron, Protandren | 8 days |
| Methandriol bisenanthoyl acetate | Oil solution | Notandron Depot | 16 days |
| Metenolone acetate | Oil solution | Primobolan | 3 days |
| Metenolone enanthate | Oil solution | Primobolan Depot | 14 days |
| Note: All are via i.m. injection. Footnotes: = TP, TV, and TUe. = TP and TKL. = TP, TPP, TiCa, and TD. = Studied but never marketed. = Developmental code names. Sources: See template. | |||
See also
References
- Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 642–. ISBN 978-1-4757-2085-3.
- Kimmig J (14 March 2013). Therapie der Haut- und Geschlechtskrankheiten. Springer-Verlag. pp. 507–. ISBN 978-3-642-94850-3.
- ^ Hellbrügge T, Opitz H, Schmid F (14 December 2013). Pädiatrische Therapie. Springer-Verlag. pp. 303–. ISBN 978-3-662-34511-5.
- ^ Arends G, Zörnig H, Hager H, Frerichs G, Kern W (14 December 2013). Hagers Handbuch der pharmazeutischen Praxis: Für Apotheker, Arzneimittelhersteller, Drogisten, Ärzte u. Medizinalbeamte. Springer-Verlag. pp. 1145–. ISBN 978-3-662-36329-4.
- ^ Schuermann H, Doepfmer R (1960). Fertilitätsstörungen beim Manne. Springer-Verlag. pp. 260–. ISBN 978-3-642-94784-1.
| Androgen receptor modulators | |||||||
|---|---|---|---|---|---|---|---|
| ARTooltip Androgen receptor |
| ||||||
| GPRC6A |
| ||||||
 | This drug article relating to the genito-urinary system is a stub. You can help Misplaced Pages by expanding it. |